Stay updated on PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.

Latest updates to the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAn additional revision tag v3.3.2 was added and the v3.2.0 revision was removed from the Record History. These are minor metadata updates to the history log that do not affect the page content.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the general banner about government funding and operating status; this notice is not tied to the trial data and does not alter study records.SummaryDifference0.7%

- Check42 days agoChange DetectedThe latest version (2025-04-02) updates the Study Status and oversight details for NCT03207945, reflecting changes in the trial's current status. Related study details and locations are adjusted accordingly in the record history.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference12%

- Check78 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.3%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; 'Back to Top' link removed.SummaryDifference0.7%

Stay in the know with updates to PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.